Logo image of ACOG

ALPHA COGNITION INC (ACOG) Stock Overview

NASDAQ:ACOG - CA02074J5017 - Common Stock

8.06 USD
-0.18 (-2.18%)
Last: 8/28/2025, 5:20:00 PM

ACOG Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap130.25M
Shares16.16M
Float14.05M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.3
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO06-09 2021-06-09
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ACOG short term performance overview.The bars show the price performance of ACOG in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 30

ACOG long term performance overview.The bars show the price performance of ACOG in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ACOG is 8.06 USD. In the past month the price decreased by -11.53%.

ALPHA COGNITION INC / ACOG Daily stock chart

ACOG Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.63 367.30B
AMGN AMGEN INC 13.1 153.76B
GILD GILEAD SCIENCES INC 14.54 139.67B
VRTX VERTEX PHARMACEUTICALS INC 23.14 100.52B
REGN REGENERON PHARMACEUTICALS 12.7 61.43B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.29B
ARGX ARGENX SE - ADR 75.95 43.09B
ONC BEONE MEDICINES LTD-ADR 6.02 35.42B
INSM INSMED INC N/A 28.53B
BNTX BIONTECH SE-ADR N/A 24.50B
NTRA NATERA INC N/A 23.04B
BIIB BIOGEN INC 8.29 19.45B

About ACOG

Company Profile

ACOG logo image Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company is headquartered in Vancouver, British Columbia and currently employs 52 full-time employees. The company went IPO on 2021-06-09. The firm is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. The company is in preclinical development for the treatment of ALS.

Company Info

ALPHA COGNITION INC

c/o 1200 - 750 West Pender Street

Vancouver BRITISH COLUMBIA CA

Employees: 52

ACOG Company Website

ACOG Investor Relations

Phone: 16045649244

ALPHA COGNITION INC / ACOG FAQ

What is the stock price of ALPHA COGNITION INC today?

The current stock price of ACOG is 8.06 USD. The price decreased by -2.18% in the last trading session.


What is the ticker symbol for ALPHA COGNITION INC stock?

The exchange symbol of ALPHA COGNITION INC is ACOG and it is listed on the Nasdaq exchange.


On which exchange is ACOG stock listed?

ACOG stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ALPHA COGNITION INC stock?

7 analysts have analysed ACOG and the average price target is 20.4 USD. This implies a price increase of 153.1% is expected in the next year compared to the current price of 8.06. Check the ALPHA COGNITION INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ALPHA COGNITION INC worth?

ALPHA COGNITION INC (ACOG) has a market capitalization of 130.25M USD. This makes ACOG a Micro Cap stock.


How many employees does ALPHA COGNITION INC have?

ALPHA COGNITION INC (ACOG) currently has 52 employees.


What are the support and resistance levels for ALPHA COGNITION INC (ACOG) stock?

ALPHA COGNITION INC (ACOG) has a support level at 7.99. Check the full technical report for a detailed analysis of ACOG support and resistance levels.


Should I buy ALPHA COGNITION INC (ACOG) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ALPHA COGNITION INC (ACOG) stock pay dividends?

ACOG does not pay a dividend.


What is the Price/Earnings (PE) ratio of ALPHA COGNITION INC (ACOG)?

ALPHA COGNITION INC (ACOG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.3).


What is the Short Interest ratio of ALPHA COGNITION INC (ACOG) stock?

The outstanding short interest for ALPHA COGNITION INC (ACOG) is 0.91% of its float. Check the ownership tab for more information on the ACOG short interest.


ACOG Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ACOG Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ACOG. While ACOG has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACOG Financial Highlights

Over the last trailing twelve months ACOG reported a non-GAAP Earnings per Share(EPS) of -1.3. The EPS increased by 38.08% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -44.35%
ROE -62.75%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-160%
Sales Q2Q%N/A
EPS 1Y (TTM)38.08%
Revenue 1Y (TTM)N/A

ACOG Forecast & Estimates

7 analysts have analysed ACOG and the average price target is 20.4 USD. This implies a price increase of 153.1% is expected in the next year compared to the current price of 8.06.


Analysts
Analysts82.86
Price Target20.4 (153.1%)
EPS Next Y-1706.25%
Revenue Next YearN/A

ACOG Ownership

Ownership
Inst Owners41.72%
Ins Owners13.07%
Short Float %0.91%
Short Ratio1.99